Contact Us
|
Sitemap
About ISTA
Products
Pipeline
Careers
Investors
BEPREVE
®
(bepotastine besilate
ophthalmic solution) 1.5%
Xibrom
(bromfenac ophthalmic
solution)
®
0.09%
Istalol
®
(timolol maleate
ophthalmic solution) 0.5%
Investor Highlights
Presentations
Stock Quotes
Quarterly Fact sheet
Products
BEPREVE
Xibrom
Istalol
Vitrase
Press Releases
ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2010 Financial Results
ISTA Pharmaceuticals Initiates Clinical Development of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
ISTA Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference